| Date | Title | Description | Source |
| 24.03.2023 | Pieris Pharmaceuticals to Host Year End 2022 Investor Call a... | BOSTON, MA / ACCESSWIRE / March 24, 2023 / Pieris Pharmaceuticals, Inc. PIRS,a clinical-stage biotec... | einpresswi... |
| 28.07.2022 | Pieris Pharmaceuticals to Host Second Quarter 2022 Investor ... | BOSTON, MA / ACCESSWIRE / July 28, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-sta... | accesswire... |
| 02.06.2022 | Pieris Pharmaceuticals To Present at Jefferies Healthcare Co... | BOSTON, MA / ACCESSWIRE / June 2, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stag... | accesswire... |
| 18.02.2022 | Research on therapeutics against COVID-19: Ilse Aigner visit... | State Parliament President Ilse Aigner and other political representatives visited the biotech compa... | bio-m.org/... |
| 14.01.2022 | Pieris Pharmaceuticals : Announces Dosing of First Patient i... | January 14, 2022
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer... | marketscre... |
| 03.01.2022 | Pieris Pharmaceuticals : Announces Successful Completion of ... | January 3, 2022
Pieris Pharmaceuticals Announces
Successful Completion of Safety Milestone
and In... | marketscre... |
| 11.11.2021 | Pieris Pharmaceuticals To Participate In Upcoming Investor C... | November 11, 2021
Pieris Pharmaceuticals To Participate In Upcoming Investor Conferences
BOSTON, M... | marketscre... |
| 08.11.2021 | Pieris Pharmaceuticals and Servier Announce Dosing of First ... | November 8, 2021
Pieris Pharmaceuticals and Servier Announce Dosing of First Patient in Phase 1/2 T... | marketscre... |
| 02.11.2021 | Pieris Pharmaceuticals Reports Third Quarter 2021 Financial ... | November 2, 2021
Pieris Pharmaceuticals Reports Third
Quarter 2021 Financial Results and
Provides... | marketscre... |
| 26.10.2021 | Pieris Pharmaceuticals To Host Third Quarter 2021 Investor C... | October 26, 2021
Pieris Pharmaceuticals To Host Third Quarter 2021 Investor Call and Provide Corpor... | marketscre... |
| 06.10.2021 | Pieris Pharmaceuticals : Announces Appointments of Chief Fin... | October 6, 2021
Pieris Pharmaceuticals Announces
Appointments of Chief Financial Officer
and Chie... | marketscre... |
| 15.09.2021 | Munich proves its strength against COVID-19 at
22. Pharma T... | On September 14, the winners of the "Most Innovative Product" award in the category of lea... | bio-m.org/... |
| 09.09.2021 | Pieris Pharmaceuticals : to Participate in Upcoming Investor... | September 9, 2021
Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences
BOSTON, M... | marketscre... |
| 24.08.2021 | Pieris Pharmaceuticals : Announces PRS-220 Presentation at E... | August 24, 2021
Pieris Pharmaceuticals Announces PRS- 220 Presentation at ERS Highlighting Preclini... | marketscre... |
| 04.08.2021 | Pieris Pharmaceuticals : Reports Second Quarter 2021 Financi... | August 4, 2021
Pieris Pharmaceuticals Reports Second
Quarter 2021 Financial Results and
Provides ... | marketscre... |
| 03.08.2021 | Pieris Pharmaceuticals : Strengthens Executive R&D Leade... | August 3, 2021
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Tim Demuth, M.... | marketscre... |
| 25.06.2021 | Pieris Pharmaceuticals : Announces Inhaled CTGF Inhibitor PR... | June 25, 2021
Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmon... | marketscre... |
| 24.06.2021 | Pieris Pharmaceuticals : Receives Orphan Drug Designation fo... | June 24, 2021
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the ... | marketscre... |
| 26.05.2021 | Billion-dollar deal for Pieris | Munich-based Pieris enters into a research collaboration with Roche subsidiary Genentech on therapie... | bio-m.org/... |
| 25.05.2021 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : Annou... | May 25, 2021
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Gene... | marketscre... |
| 20.05.2021 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : to Pr... | Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
Download PDF
... | marketscre... |
| 12.04.2021 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : Prese... | BOSTON, MA - Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company adva... | marketscre... |
| 30.03.2021 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : Repor... | Pieris Pharmaceuticals Reports Full-Year 2020 Financial Results and Provides Corporate Update
Downl... | marketscre... |
| 25.03.2021 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : Annou... | Pieris Announces Amendment of Existing Immuno-oncology Multi-target Collaboration with Seagen, a Cli... | marketscre... |
| 04.11.2020 | PIERIS PHARMACEUTICALS, INC.
Pieris Pharmaceuticals : Repor... | Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
D... | marketscre... |
| 04.11.2020 | Pieris Pharmaceuticals : Reports Third Quarter 2020 Financia... | Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
D... | marketscre... |
| 21.07.2020 | Pieris slammed with FDA hold; Biogen adds PhIV for Spinraz... | → Boston-based Pieris $PIRS has been forced to hit the brakes on a slate of Phase I studies for its... | endpts.com... |
| 04.11.2019 | Tmunity teams up with Oncora Medical; T3D receives ad... | → Usman “Oz” Azam–led Tmunity Therapeutics — which recently bagged $75 million, bringing t... | endpts.com... |
| 06.09.2019 | Randy Schatzman jumps to the helm of another start-up; No... | → In biotech, long-term survival in the executive ranks can depend a lot on the quality of yo... | endpts.com... |
| 11.08.2017 | Novartis veteran David Epstein takes leadership role ... | ⇨ Novartis vet David Epstein is expanding his role at Rubius, taking the executive chairm... | endpts.com... |
| 04.05.2017 | AstraZeneca and Pieris Pharmaceuticals collaborate on treatm... | AstraZeneca and Pieris Pharmaceuticals collaborate on treatments for respiratory diseases
04-05-201... | cambridgen... |
| 03.05.2017 | AstraZeneca commits $57.5M to seed Anticalin R&D pac... | Stephen Yoder
Boston-based Pieris Pharmaceuticals has rolled out its second big-money colla... | endpts.com... |
| 27.02.2017 | Pieris inks a licensing deal for Japan; Kindler joins Phar... | Stephen Yoder, Pieris CEO
→ Boston-based Pieris $PIRS has optioned a licensing pact giving AS... | endpts.com... |
| 19.12.2014 | Forbion Portfolio Company Pieris Pharmaceuticals, Inc. Goes ... | Pieris Pharmaceuticals, Inc. (OTC:PIRS) (formerly Marika, Inc.), a Nevada corporation, announced tod... | forbion.co... |
| 18.12.2014 | Pieris Pharmaceuticals, Inc. Goes Public, Raises $12.2 Milli... | Completion of alternative public offering in which Pieris AG becomes a wholly-owned subsidiary of Pi... | gildehealt... |
| 19.10.2011 | Pieris Receives EUR 6 million Grant to Novel Anticalin Thera... | Freising, Germany - In concert with the award of the EU FP7 Grant to the Pieris-led EUROCALIN Consor... | gildehealt... |
| 27.03.2008 | Pieris Raises EUR 25 million in Series B Financing Round | FREISING-WEIHENSTEPHAN, Germany - Pieris AG, a bio-pharmaceutical company developing Anticalins(R), ... | gildehealt... |
| 27.03.2008 | Forbion’s Portfolio Company Pieris AG raises € 25 M (US$ 38M... | - | forbion.co... |
